25 May 2013
Keywords: fournier, copromote, baycol, canada, pharma, thylmer, division
Article | 13 January 1998
Fournier Pharma of Canada's Thylmer Division (formed in July 1997) hasnegotiated copromotion rights to Bayer's new HMG-CoA reductase inhibitor Baycol (cerivastatin) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.